All lobbying filings
MEHLMAN CONSULTING, INC.
Lobbying for ELEVANCE HEALTH, INC. · Health Benefits Provider
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$90,000
What the client paid this registrant for the period.
Client based in
Indiana
Lobbyists on this filing
1
-
SEAN BRADY New on this filingPreviously held: Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)
Government bodies contacted
2
Lobbying activity
4
Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Issues related to Surprise Billing.
Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. S. 1105 - No UPCODE Act. H.R. 5243 - To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. H.R. 4093 - Apples to Apples Comparison Act of 2026.
Prescription Drug Pricing.
Issues related to tax-preferred accounts to help lower the cost of insurance.